Five-year retrospective review of guideline-based management of fungal endophthalmitis

Acta Ophthalmologica

Volumn 86, Issue 5, 2008, Pages 525-532

  Narendran, Niro ^a   Balasubramaniam, Balini ^a   Johnson, Elizabeth ^b   Dick, Andrew ^a   Mayer, Eric ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Amphotericin; Candida albicans; Fluconazole; Flucytosine; Fungal endophthalmitis; Voriconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; SILICONE OIL; STEROID; VORICONAZOLE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; DRUG PENETRATION; EVIDENCE BASED MEDICINE; EYE INJURY; EYE SURGERY; FEMALE; FUNGAL ENDOPHTHALMITIS; FUNGUS CULTURE; FUSARIUM; HEALTH CARE COST; HOSPITAL INFORMATION SYSTEM; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY DIAGNOSIS; MALE; MEDICAL AUDIT; OPTIC NERVE TUMOR; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG COSTS; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FLUCONAZOLE; FLUCYTOSINE; GUIDELINE ADHERENCE; HEALTH CARE COSTS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; MYCOSES; PRACTICE GUIDELINES AS TOPIC; PYRIMIDINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZOLES; VISUAL ACUITY;

EID: 48449086736     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.01097.x     Document Type: Article

References (13)

1. Anand A, Madhavan H, Neelam V & Lily T (2001): Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology 108: 326-330.
2. Brod RD, Flynn HW Jr, Clarkson JG, Pflugfelder SC, Culbertson WW & Miller D (1990): Endogenous Candida endophthalmitis; management without intravenous amphotericin B. Ophthalmology 97: 666-672.
3. Edwards JEJ, Bodey GP, Bowden RA et.al. (1997): International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 25: 43-59.
4. Han DP, Wisniewski SR, Kelsey SF, Doft BH, Barza M & Pavan PR (1999): Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 19: 98-102.
5. Klotz SA, Penn CC, Negvesky GJ & Butrus SI (2000): Fungal and parasitic infections of the eye. Clin Microbiol Rev 13: 662-685.
6. Notheis G, Tarani L, Costantino F et al. (2006): Posaconazole for treatment of refractory invasive fungal disease. Mycoses 49(Suppl. 1): 37-41.
7. Okhravi N, Adamson P & Lightman S (2000): Use of PCR in endophthalmitis. Ocul Immunol Inflamm 8: 189-200.
8. Ricci F, Cedrone C & Cerulli L (1998): Standardized measurement of visual acuity. Ophthalmic Epidemiol 5: 41-53.
9. Sanati H, Belanger P, Fratti R & Ghannoum M (1997): A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 41: 2492-2496.
10. Sheehan DJ, Hitchcock CA & Sibley CM (1999): Current and emerging azole antifungal agents. Clin Microbiol Rev 12: 40-79.
11. Shimbo M, Ito N & Kadonosono K (2002): Investigation of beta-D-glucan values in the vitreous. Nippon Ganka Gakkai Zasshi 106: 579-582.
12. Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M & Qiu H (2001): Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina 21: 203-209.
13. Tarai B, Gupta A, Ray P, Shivaprakash MR & Chakrabarti A. (2006): PCR for early diagnosis of post-operative fungal endophthalmitis. Indian J Med Res 123: 671-678.